These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19901203)

  • 21. Sealing the left atrial appendage: ready for prime time?
    El-Chami MF; Hoffman M; Lerakis S
    Am J Med Sci; 2007 May; 333(5):285-9. PubMed ID: 17505170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left atrial appendectomy and maze.
    Bonanomi G; Zenati MA; Schwartzman D
    J Am Coll Cardiol; 2003 Jan; 41(1):170; author reply 170-1. PubMed ID: 12570963
    [No Abstract]   [Full Text] [Related]  

  • 23. Strategies to improve uptake of modalities for reducing embolic risk.
    Jolobe OM
    Eur J Intern Med; 2011 Jun; 22(3):e18; author reply e19. PubMed ID: 21570631
    [No Abstract]   [Full Text] [Related]  

  • 24. Atrial fibrillation: the ancient conundrum defies simple solution.
    Goldman ME; Croft LB
    J Am Coll Cardiol; 2005 Jun; 45(11):1813-4. PubMed ID: 15936611
    [No Abstract]   [Full Text] [Related]  

  • 25. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.
    Holmes DR; Kar S; Price MJ; Whisenant B; Sievert H; Doshi SK; Huber K; Reddy VY
    J Am Coll Cardiol; 2014 Jul; 64(1):1-12. PubMed ID: 24998121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.
    Grosset-Janin D; Barth E; Bertrand B; Detante O
    Rev Neurol (Paris); 2015 May; 171(5):426-32. PubMed ID: 25912470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
    Le D; Morelli R; Badhwar N; Lee RJ
    Expert Rev Cardiovasc Ther; 2015; 13(8):907-14. PubMed ID: 26070218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stroke in a patient with a surgically ligated left atrial appendage: should warfarin be continued after left atrial appendage ligation?
    Kanjwal K; Colyer WR
    Am J Ther; 2011 Jul; 18(4):e117-8. PubMed ID: 20093925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation.
    Black-Maier E; Piccini JP; Granger CB
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2968-2976. PubMed ID: 31520437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5-Year, Long-Term Data.
    Reddy VY; Akehurst RL; Gavaghan MB; Amorosi SL; Holmes DR
    J Am Heart Assoc; 2019 Jul; 8(13):e011577. PubMed ID: 31230500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left atrial appendage closure is preferred to chronic warfarin therapy: the pro perspective.
    Atoui M; Gunda S; Lakkireddy D
    Card Electrophysiol Clin; 2015 Sep; 7(3):403-13. PubMed ID: 26304519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left Atrial Appendage Management: No Better Time Than the Present.
    Romano MA; Bergquist CS
    Innovations (Phila); 2019; 14(6):498-502. PubMed ID: 31840574
    [No Abstract]   [Full Text] [Related]  

  • 33. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
    Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
    Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left Atrial Appendage Closure to Reduce the Risk of Thromboembolic Complications in Atrial Fibrillation: Pay Now and Possibly Pay Later?
    Waks JW; Manning WJ
    J Am Coll Cardiol; 2015 Jun; 65(24):2624-2627. PubMed ID: 26088301
    [No Abstract]   [Full Text] [Related]  

  • 35. History of Percutaneous Left Atrial Appendage Occlusion with AMPLATZER Devices.
    Meier B; Stegink W; Tzikas A
    Interv Cardiol Clin; 2018 Apr; 7(2):151-158. PubMed ID: 29526284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thoracoscopic Left Atrial Appendage Occlusion for Stroke Prevention Compared with Long-Term Warfarin Therapy in Patients With Nonvalvular Atrial Fibrillation.
    Fu M; Qin Z; Zheng S; Li Y; Yang S; Zhao Y; Hu C; Zhou K; Zhou Y; Meng X
    Am J Cardiol; 2019 Jan; 123(1):50-56. PubMed ID: 30385030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left atrial appendage closure for stroke prevention in atrial fibrillation: state of the art and current challenges.
    Syed TM; Halperin JL
    Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):428-35. PubMed ID: 17653115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accurate echocardiographic assessment of left atrial appendage ostium and peri-device flow in device closure.
    Ren JF
    J Am Coll Cardiol; 2012 Oct; 60(15):1432-3; author reply 1433-4. PubMed ID: 23036629
    [No Abstract]   [Full Text] [Related]  

  • 39. Warfarin: an inconvenient truth.
    Gattellari M; Worthington J; Zwar N
    Stroke; 2009 Jan; 40(1):5-7. PubMed ID: 18757283
    [No Abstract]   [Full Text] [Related]  

  • 40. Contemporary trends in utilization and outcomes of percutaneous left atrial appendage occlusion in the United States from 2016 to 2019.
    Gupta M; Minhas AMK; Goel SS; Dani SS; Alam M; Nazir S; Khan SU; Aronow W; Jain V
    Heart Rhythm; 2023 Feb; 20(2):313-314. PubMed ID: 36257480
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.